SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

Novartis CEO Says Planned US China Biotech Investment Limits May Hurt Drug Development

Novartis CEO Vas Narasimhan said planned U.S. restrictions on investment in Chinese biotechnology may hurt drug development.

Related stories